Regeneron Pharmaceuticals Inc
XBER:RGO

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
XBER:RGO
Watchlist
Price: 128.94 EUR 0.71% Market Closed
Market Cap: 13.9B EUR

Wall Street
Price Targets

RGO Price Targets Summary
Regeneron Pharmaceuticals Inc

Wall Street analysts forecast RGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGO is 681.7 EUR with a low forecast of 542.33 EUR and a high forecast of 950.47 EUR.

Lowest
Price Target
542.33 EUR
321% Upside
Average
Price Target
681.7 EUR
429% Upside
Highest
Price Target
950.47 EUR
637% Upside
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
31% Upside
MRNA
Moderna Inc
8% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
66% Upside
RCUS
Arcus Biosciences Inc
41% Upside
ARX
Aroa Biosurgery Ltd
21% Upside
VNDA
Vanda Pharmaceuticals Inc
70% Upside
RCKT
Rocket Pharmaceuticals Inc
128% Upside
RYTM
Rhythm Pharmaceuticals Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Regeneron Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 4 years is 6%.

31%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 4 years is 13%.

N/A
Past Growth
13%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 4 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGO's stock price target?
Price Target
681.7 EUR

According to Wall Street analysts, the average 1-year price target for RGO is 681.7 EUR with a low forecast of 542.33 EUR and a high forecast of 950.47 EUR.

What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 4 years is 6%.

What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
13%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 4 years is 13%.

What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 4 years is 8%.

Back to Top